#USA #Minnetonka #GMP #Laboratory #DDL

DDL Strengthens its GMP Laboratory Expertise

DDL, a well-known player in the third-party testing laboratory sector, is excited to unveil the latest developments in its laboratory operations. The company has recently appointed two seasoned professionals, Amy Miller as Senior Director of Lab Support Services and Scientific Affairs and Bob Anderson as Director of Lab Operations. This move signals a significant step forward in the company’s mission to enhance its GMP testing services for the life sciences industry and drug delivery testing.

Amy Miller: A Wealth of Experience

Amy Miller brings 28 years of invaluable experience to DDL, having made notable contributions as a technical and strategic leader in the realms of pharmaceutical component manufacturing and medical device services. Her extensive background spans the full scope of CDMO (Contract Development and Manufacturing Organization) environments. Over the years, Miller has excelled in building high-performing global teams and aligning diverse stakeholders around common strategic objectives. This strategic insight will lead DDL in expanding its testing capabilities to address the ever-evolving needs in pharmaceutical packaging and drug delivery systems.

Bob Anderson: Deep Industry Insight

Joining Amy is Bob Anderson, who boasts an impressive 30 years of experience concentrated in pharmaceutical product development, analytical chemistry, and cGMP laboratory operations. Anderson has made substantial contributions in constructing high-performing teams and nurturing client relationships while managing complex projects. His expertise primarily focuses on platforms that facilitate inhalation, transdermal, and microneedle deliveries. He has guided products from early-stage development phases right through to regulatory submissions, ensuring that they meet the necessary post-approval requirements.

Enhancing Laboratory Operations and Capability

With these new appointments, DDL is positioning itself to significantly enhance its GMP laboratory capabilities. The Vice President of Analytical Testing Services, Jennifer Riter, emphasized that adding experienced professionals like Miller and Anderson bolsters both scientific expertise and operational leadership at the GMP lab. Their combined knowledge will be instrumental in navigating the complexities of pharmaceutical containment, packaging, and drug delivery testing, thus ensuring heightened support for customers who face rigorous regulatory challenges.

The appointments are part of a broader strategy to invest in GMP testing capabilities and consulting services at DDL. The organization currently operates an FDA-registered laboratory in Minnetonka, Minnesota, which plays a crucial role in delivering its comprehensive GMP testing services. This facility conducts a wide range of testing, including ICH stability studies, performance evaluations, and container closure integrity testing (CCIT), specifically aimed at drug-device combinations such as auto-injectors and prefilled syringes.

DL's commitment to providing regulatory-compliant testing services places it at the forefront of the life sciences sector, supporting pharma, biotech, and medical device industries. Presently, DDL has established a significant footprint with testing laboratories located not only in Eden Prairie and Minnetonka, Minnesota but also in Irvine, California, and Edison, New Jersey.

For those interested in DDL's GMP services or seeking a quote, visit DDL Testing or reach out at 800-229-4235.

In conclusion, DDL is not just expanding its team; it is effectively enhancing its capabilities to support its client's complex needs while staying committed to excellence in the life sciences industry.